Antares Pharma (ATRS) Posts Q3 Loss of 3c/Share
Antares Pharma (Nasdaq: ATRS) reported Q3 EPS of ($0.03), $0.01 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
